SPY456.49-8.23 -1.77%
DIA353.85-5.29 -1.47%
IXIC14,506.90-386.86 -2.60%

BRIEF-Mymd Pharmaceuticals Investment Company Oravax Medical Signs Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10 Million Doses Of Oral Covid-19 Vaccine To Be Commercialized In Southeast Asia

reuters.com · 12/29/2021 09:23
BRIEF-Mymd Pharmaceuticals Investment Company Oravax Medical Signs Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10 Million Doses Of Oral Covid-19 Vaccine To Be Commercialized In Southeast Asia

- MyMD Pharmaceuticals Inc MYMD:

  • MYMD PHARMACEUTICALS INVESTMENT COMPANY ORAVAX MEDICAL SIGNS COOPERATION AND PURCHASE AGREEMENT FOR INITIAL PRE-PURCHASE OF 10 MILLION DOSES OF ORAL COVID-19 VACCINE TO BE COMMERCIALIZED IN SOUTHEAST ASIA

  • MYMD PHARMACEUTICALS INC - ORAMED AND MYMD ARE CURRENTLY EVALUATING SEVERAL OPTIONS WITH RESPECT TO THEIR INTEREST IN ORAVAX

  • MYMD PHARMACEUTICALS INC - OPTIONS INCLUDE A POTENTIAL DISTRIBUTION OF ORAVAX SHARES TO BOTH ORAMED AND MYMD SHAREHOLDERS

Source text for Eikon: ID:nBw9spdBya

Further company coverage: MYMD


((Reuters.Briefs@thomsonreuters.com;))